非暴露式LECS(CLEAN-NET)治疗胃癌的长期结局:保留功能策略与选择性淋巴结评估
该回顾性队列分析19例临床诊断cT1N0胃癌患者接受CLEAN-NET的长期肿瘤学结局,中位随访6.2年。术后14例(73.7%)因病理危险因素归为eCuraC-2,15例接受有限区域淋巴结清扫,1例发现淋巴结转移。CLEAN-NET治疗的胃癌无复发,但2例保留胃发生异时性胃癌。
要点
- CLEAN-NET治疗的胃癌在中位6.2年随访中无复发。
- 73.7%患者术后病理归为eCuraC-2,提示术前分期低估风险。
- 保留胃发生异时性胃癌2例,其中1例死亡。
核心结论
- CLEAN-NET治疗的胃癌未观察到复发,但该历史队列不能确立CLEAN-NET作为指南推荐胃切除术的替代。
- 结果可为未来保留功能、非暴露局部切除联合验证性淋巴结导航策略的研究提供参考。
研究设计与样本
- 治疗选择基于当时可用的术前临床分期。
- 选择性病例行有限区域淋巴结评估,病理结果按eCura系统分类。
主要发现
- 中位随访6.2年,随访最长至16.8年。
- 14例(73.7%)术后病理归为eCuraC-2。
- 15例接受有限区域淋巴结清扫,1例发现病理淋巴结转移。
- 3例接受追加手术。
- CLEAN-NET治疗的胃癌无复发;保留胃发生异时性胃癌2例,其中1例死于异时性胃癌。
临床怎么用
- CLEAN-NET不作为指南推荐胃切除术的替代方案。
- 临床cT1N0胃癌行局部切除时需重视术后病理eCura评估,本队列73.7%归为eCuraC-2。
- 保留胃患者需长期随访监测异时性胃癌。
局限性
- 回顾性历史队列,样本量仅19例。
- 治疗选择基于早期技术开发阶段的术前临床分期。
- 随访期间存在异时性胃癌及非胃癌死亡事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-exposure laparoscopic and endoscopic cooperative surgery (LECS), known as CLEAN-NET (combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique), was developed for gastric submucosal tumors; however, its oncologic validity for gastric cancer remains unclear. We evaluated long-term oncologic outcomes of CLEAN-NET in patients with clinically diagnosed cT1N0 gastric cancer during the early developmental phase of this technique. METHODS: We retrospectively analyzed 19 consecutive patients who underwent CLEAN-NET between December 2008 and June 2010. Treatment selection was based on preoperative clinical staging available at that time. Limited regional lymph node assessment was performed in selected cases, and pathological findings were classified according to the eCura system. Recurrence of the gastric cancer treated by CLEAN-NET, metachronous gastric cancer, overall survival, and causes of death were evaluated. RESULTS: The median follow-up period was 6.2 years, with follow-up extending up to 16.8 years. Although treatment selection was based on preoperative cT1N0 assessment, 14 patients (73.7%) were subsequently classified as eCuraC-2 because of postoperative pathological risk factors. Limited regional lymph node dissection was performed in 15 patients, and pathological lymph node metastasis was identified in 1 patient. Additional surgery was performed in 3 patients. No recurrence of the gastric cancer treated by CLEAN-NET was observed. Metachronous gastric cancer developed in the preserved stomach in 2 patients, including 1 death from metachronous gastric cancer. During follow-up, 3 patients died: 1 from lung cancer, 1 from metachronous gastric cancer, and 1 from pneumonia. CONCLUSION: This historical cohort provides rare ultra-long-term observational data after CLEAN-NET for gastric cancer. Although no recurrence of the gastric cancer treated by CLEAN-NET was observed, the findings do not establish CLEAN-NET as an alternative to guideline-recommended gastrectomy. Rather, they may inform future studies of function-preserving, non-exposure local resection combined with validated nodal navigation strategies.
引用
- Onimaru M, Inoue H, Nakahara K, et al. Non-exposure LECS (CLEAN-NET) for gastric cancer: long-term outcomes of a function-preserving strategy with selective nodal assessment. Surg Endosc. 2026. PMID: 42448965. doi:10.1007/s00464-026-13139-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。